Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02541565
Title Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

diffuse large B-cell lymphoma

Therapies

Pembrolizumab

Cyclophosphamide + Doxorubicin + Prednisone + Vincristine Sulfate

Rituximab

Age Groups: adult
Covered Countries USA


No variant requirements are available.